🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chronic-phase chronic myelogenous leukemia (CML) a...
Status
Unknown
Location
the First Affiliated Hospital of Harbin Medical University
Start Date
2018-05-01
Trial ID
NCT03515018
Treatments Being Tested
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The extension study followed the core study CAMN107ECN02 (NCT01275196). whi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-17
Trial ID
NCT02272777
Assuming that PDR001, an anti-PD-1 antibody, with imatinib might be effecti...
Status
Completed
Location
Asan Medical Center
Start Date
2019-02-14
Trial ID
NCT03609424
Treatments Being Tested
To evaluate efficacy, safety and pharmacokinetic profile of asciminib 40mg+...
Status
Completed
Location
Georgia Regents University
Start Date
2018-11-22
Trial ID
NCT03578367
Treatments Being Tested
Prior to the implementation of preoperative imatinib mesylate therapy, a co...
Status
Not Yet Recruiting
Location
Weizhong Jiang
Start Date
2023-10-01
Trial ID
NCT05970900
Treatments Being Tested
Research Hypothesis: Treatment with dasatinib 100 mg QD is superior to ima...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00854841
Treatments Being Tested
In this study, the efficacy and safety of two radotinib doses, 300 mg twice...
Status
Completed
Location
Local Institution
Start Date
2011-08
Trial ID
NCT01511289
This is a Phase III, multi-center, open-label, parallel, 2-arm, randomized ...
Status
Active Not Recruiting
Location
Peking University People's Hospital(北京大学人民医院)
Start Date
2018-12-28
Trial ID
NCT03722420
This is a phase I/II, open-label, non-randomized, multicentre study to eval...
Status
Completed
Location
Severance Hospital, Yonsei University Health System
Start Date
2019-04-15
Trial ID
NCT03802084
Treatments Being Tested